• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

介入治疗对下肢动脉硬化闭塞症的临床疗效及预后因素分析。

Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors.

机构信息

General Surgery, The First People's Hospital of WenLing, No. 333, Chuanan Road, Wenling City, 317500 Zhejiang Province, China.

出版信息

Comput Math Methods Med. 2022 Aug 4;2022:9190292. doi: 10.1155/2022/9190292. eCollection 2022.

DOI:10.1155/2022/9190292
PMID:35966252
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9371862/
Abstract

OBJECTIVE

This study was designed to analyse the clinical efficacy of interventional therapy on lower extremity arteriosclerosis obliterans (LEASO) and prognostic factors.

METHODS

A total of 122 patients with LEASO diagnosed in our hospital from March 2017 to March 2019 were retrospectively analysed. Among them, 72 patients who received conservative therapy were assigned to a conservative group, and 50 patients who received interventional therapy additionally based on conservative therapy were assigned to an intervention group. The short-term (12 weeks after therapy) and long-term (3 years after therapy) clinical efficacies on the two groups were compared. Death, amputation, and vascular restenosis (vascular stenosis > 50% in computed tomography reexamination) were defined as unfavourable outcomes, and Cox regression was conducted to analyze the factors influencing the prognosis of patients. The incidence of adverse events in the two groups within 3 years was compared and statistically analyzed. Additionally, the hospital stay, therapy cost, claudication distance, and ankle brachial index were compared between the two groups.

RESULTS

After therapy, the conservative group showed a notably lower total effective rate than the intervention group ( < 0.05), but the clinical efficacy after 3 years was similar between the two groups ( > 0.05). Additionally, the conservative group experienced notably longer hospital stay than the intervention group ( < 0.05), and cost less in treatment than the intervention group ( < 0.05). However, the conservative group experienced a notably shorter claudication distance and showed a notably lower ankle brachial index than the intervention group ( < 0.05). The two groups were not significantly different in mortality, amputation rate, and vascular restenosis rate ( > 0.05). Moreover, Cox regression analysis revealed that age and conservative therapy were independent risk factors for the prognosis of patients ( < 0.05).

CONCLUSION

Interventional therapy can substantially improve the short-term efficacy and prognosis of patients with LEASO, but the cost is high, so the therapeutic regimen should be selected according to the patient's economic condition.

摘要

目的

本研究旨在分析介入治疗下肢动脉硬化闭塞症(LEASO)的临床疗效及其预后因素。

方法

回顾性分析 2017 年 3 月至 2019 年 3 月我院收治的 122 例 LEASO 患者,其中接受保守治疗的 72 例患者分为保守组,在保守治疗的基础上额外接受介入治疗的 50 例患者分为介入组。比较两组患者短期(治疗后 12 周)和长期(治疗后 3 年)的临床疗效。死亡、截肢和血管再狭窄(计算机断层复查血管狭窄>50%)定义为不良结局,并采用 Cox 回归分析影响患者预后的因素。比较两组患者 3 年内不良事件的发生率并进行统计学分析。同时比较两组患者的住院时间、治疗费用、跛行距离和踝肱指数。

结果

治疗后,保守组总有效率明显低于介入组(<0.05),但两组 3 年后的临床疗效相似(>0.05)。此外,保守组的住院时间明显长于介入组(<0.05),治疗费用明显低于介入组(<0.05)。但保守组的跛行距离明显短于介入组,踝肱指数明显低于介入组(<0.05)。两组患者的死亡率、截肢率和血管再狭窄率差异无统计学意义(>0.05)。Cox 回归分析显示,年龄和保守治疗是影响患者预后的独立危险因素(<0.05)。

结论

介入治疗可显著提高 LEASO 患者的短期疗效和预后,但费用较高,因此应根据患者的经济状况选择治疗方案。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f270/9371862/762683b0af8b/CMMM2022-9190292.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f270/9371862/8a1360cfe5c0/CMMM2022-9190292.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f270/9371862/762683b0af8b/CMMM2022-9190292.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f270/9371862/8a1360cfe5c0/CMMM2022-9190292.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f270/9371862/762683b0af8b/CMMM2022-9190292.002.jpg

相似文献

1
Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors.介入治疗对下肢动脉硬化闭塞症的临床疗效及预后因素分析。
Comput Math Methods Med. 2022 Aug 4;2022:9190292. doi: 10.1155/2022/9190292. eCollection 2022.
2
Effect of diabetes on the prognosis, serum inflammatory factors, and quality of life of patients with lower extremity arteriosclerosis obliterans after vascular intervention: a retrospective comparative cohort study.糖尿病对下肢动脉硬化闭塞症患者血管介入治疗后预后、血清炎症因子及生活质量的影响:一项回顾性对比队列研究。
Ann Palliat Med. 2022 Aug;11(8):2720-2729. doi: 10.21037/apm-22-827.
3
The clinical significance of serum HMGB1 in patients with lower extremity arteriosclerosis obliterans after interventional vascular restenosis.血清高迁移率族蛋白B1在下肢动脉硬化闭塞症患者血管介入术后再狭窄中的临床意义
Front Surg. 2023 Jan 6;9:1031108. doi: 10.3389/fsurg.2022.1031108. eCollection 2022.
4
Effect of alprostadil plus cilostazol on the treatment outcomes and inflammatory factors in patients with lower extremity arteriosclerosis obliterans receiving evidence-based care.前列地尔联合西洛他唑对接受循证护理的下肢动脉硬化闭塞症患者治疗效果及炎症因子的影响。
Clin Hemorheol Microcirc. 2024;87(4):405-413. doi: 10.3233/CH-232068.
5
Novel Insight Into Long-Term Risk of Major Adverse Cardiovascular and Cerebrovascular Events Following Lower Extremity Arteriosclerosis Obliterans.下肢动脉硬化闭塞症后主要心血管和脑血管不良事件的长期风险新见解。
Front Cardiovasc Med. 2022 Apr 4;9:853583. doi: 10.3389/fcvm.2022.853583. eCollection 2022.
6
Expression level and clinical significance of LncRNA PVT1 in the serum of patients with LEASO.LncRNA PVT1 在 LEASO 患者血清中的表达水平及临床意义。
PeerJ. 2023 Sep 19;11:e16057. doi: 10.7717/peerj.16057. eCollection 2023.
7
Effect of hydration therapy and nursing intervention on preventing contrast-induced nephropathy after interventional treatment of lower extremity arteriosclerosis obliterans.水化疗法及护理干预对预防下肢动脉硬化闭塞症介入治疗后对比剂肾病的影响。
Technol Health Care. 2024;32(3):1361-1369. doi: 10.3233/THC-230256.
8
Increased plasma olfactomedin 2 after interventional therapy is a predictor for restenosis in lower extremity arteriosclerosis obliterans patients.介入治疗后血浆嗅鞘蛋白2升高是下肢动脉硬化闭塞症患者再狭窄的预测指标。
Scand J Clin Lab Invest. 2018 Jul;78(4):269-274. doi: 10.1080/00365513.2018.1452287. Epub 2018 Mar 19.
9
The Effect of Multidimensional Nursing Intervention for Pain on Pain Levels in Patients with Lower Extremity Arteriosclerosis Obliterans.多维护理干预对下肢动脉硬化闭塞症患者疼痛程度的影响。
Altern Ther Health Med. 2022 Jul;28(5):38-43.
10
[Efficacy of drug-coated balloon and common balloon for treatment of superficial femoral artery and popliteal artery arteriosclerosis obliterans: prospective randomized controlled triac].药物涂层球囊与普通球囊治疗股浅动脉及腘动脉硬化闭塞症的疗效:前瞻性随机对照试验
Nan Fang Yi Ke Da Xue Xue Bao. 2017 Mar 20;37(3):296-300. doi: 10.3969/j.issn.1673-4254.2017.03.03.

引用本文的文献

1
Percutaneous transluminal angioplasty with stenting for the treatment of lower limb arteriosclerosis obliterans.经皮腔内血管成形术联合支架置入治疗下肢动脉硬化闭塞症。
Wideochir Inne Tech Maloinwazyjne. 2024 Nov 28;19(4):465-469. doi: 10.20452/wiitm.2024.17915. eCollection 2024 Dec 27.
2
Accuracy of 3D CE-MRA combined with ultrasound microbubble angiography for the diagnosis of lower extremity atherosclerotic occlusion.三维对比增强磁共振血管造影联合超声微泡血管造影诊断下肢动脉粥样硬化闭塞症的准确性
Am J Transl Res. 2025 Feb 15;17(2):818-831. doi: 10.62347/HVBK1487. eCollection 2025.
3
Retracted: Clinical Efficacy of Interventional Therapy on Lower Extremity Arteriosclerosis Obliterans and Prognostic Factors.

本文引用的文献

1
[Progress and prospect of the treatment of lower extremity arteriosclerosis obliterans].[下肢动脉硬化闭塞症治疗的进展与展望]
Zhonghua Wai Ke Za Zhi. 2021 Dec 1;59(12):961-964. doi: 10.3760/cma.j.cn112139-20210923-00453.
2
[Basic principles and approaches to medical rehabilitation of patients with atherosclerosis obliterans of lower limb arteries].[下肢动脉闭塞性动脉粥样硬化患者医学康复的基本原则与方法]
Vopr Kurortol Fizioter Lech Fiz Kult. 2021;98(4):54-61. doi: 10.17116/kurort20219804154.
3
Virtual Reality-Assisted Percutaneous Transluminal Angioplasty for Interventional Treatment of Lower-Extremity Arteriosclerosis Obliterans.
撤回:下肢动脉硬化闭塞症介入治疗的临床疗效及预后因素
Comput Math Methods Med. 2023 Jun 28;2023:9871829. doi: 10.1155/2023/9871829. eCollection 2023.
虚拟现实辅助经皮腔内血管成形术治疗下肢动脉硬化闭塞症。
J Healthc Eng. 2021 Jul 27;2021:9975583. doi: 10.1155/2021/9975583. eCollection 2021.
4
Analysis of the effect of color Doppler ultrasonography in the diagnosis of arteriosclerotic occlusive disease of lower extremities.
Minerva Surg. 2022 Apr;77(2):188-191. doi: 10.23736/S2724-5691.21.09031-6. Epub 2021 Aug 3.
5
Author's response to the comments on "Preoperative sepsis is a predictive factor for 30-day mortality after major lower limb amputation among patients with arteriosclerosis obliterans and diabetes".
J Orthop Sci. 2020 Nov;25(6):1133-1134. doi: 10.1016/j.jos.2020.08.006. Epub 2020 Sep 29.
6
[Early outcomes of therapy and indirect revascularization surgery in patients with critical ischemia of lower extremities].[下肢严重缺血患者的治疗及间接血运重建手术的早期疗效]
Khirurgiia (Mosk). 2020(8):55-60. doi: 10.17116/hirurgia202008155.
7
A risk predictor of restenosis after superficial femoral artery stent implantation: relevance of mean platelet volume.股浅动脉支架植入术后再狭窄的风险预测指标:血小板平均体积的相关性。
BMC Cardiovasc Disord. 2020 Aug 8;20(1):361. doi: 10.1186/s12872-020-01633-8.
8
Effects of Valsartan on Restenosis in Patients with Arteriosclerosis Obliterans of the Lower Extremities Undergoing Interventional Therapy: A Prospective, Randomized, Single-Blind Trial.血管紧张素受体拮抗剂缬沙坦对下肢动脉硬化闭塞症介入治疗后再狭窄的影响:前瞻性、随机、单盲试验。
Med Sci Monit. 2020 Jun 16;26:e919977. doi: 10.12659/MSM.919977.
9
Clinical Significance of Endothelin-1 And C Reaction Protein in Restenosis After the Intervention of Lower Extremity Arteriosclerosis Obliterans.内皮素-1 和 C 反应蛋白在下肢动脉硬化闭塞症介入治疗后再狭窄中的临床意义。
J Invest Surg. 2021 Jul;34(7):765-770. doi: 10.1080/08941939.2019.1690600. Epub 2020 Jan 29.
10
miR-21 regulates vascular smooth muscle cell function in arteriosclerosis obliterans of lower extremities through AKT and ERK1/2 pathways.微小RNA-21通过AKT和ERK1/2信号通路调控下肢动脉硬化闭塞症中血管平滑肌细胞的功能。
Arch Med Sci. 2019 Oct;15(6):1490-1497. doi: 10.5114/aoms.2018.78885. Epub 2018 Oct 11.